Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravdin, P. M.
Right arrow Articles by Parker, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravdin, P. M.
Right arrow Articles by Parker, H. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 19, Issue 4 (February), 2001: 980-991
© 2001 American Society for Clinical Oncology

Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer

By Peter M. Ravdin, Laura A. Siminoff, Greg J. Davis, Mary Beth Mercer, Joan Hewlett, Nancy Gerson, Helen L. Parker

From the University of Texas Health Sciences Center, San Antonio, TX, and Case Western Reserve, Cleveland, OH.

Address reprint requests to Peter M. Ravdin, MD, PhD, Division of Oncology, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78284; email: pravdin@ swog.org.

PURPOSE: The goal of the computer program Adjuvant! is to allow health professionals and their patients with early breast cancer to make more informed decisions about adjuvant therapy.

METHODS: Actuarial analysis was used to project outcomes of patients with and without adjuvant therapy based on estimates of prognosis largely derived from Surveillance, Epidemiology, and End-Results data and estimates of the efficacy of adjuvant therapy based on the 1998 overviews of randomized trials of adjuvant therapy. These estimates can be refined using the Prognostic Factor Impact Calculator, which uses a Bayesian method to make adjustments based on relative risks conferred and prevalence of positive test results.

RESULTS: From the entries of patient information (age, menopausal status, comorbidity estimate) and tumor staging and characteristics (tumor size, number of positive axillary nodes, estrogen receptor status), baseline prognostic estimates are made. Estimates for the efficacy of endocrine therapy (5 years of tamoxifen) and of polychemotherapy (cyclophosphamide/methotrexate/fluorouracil–like regimens, or anthracycline-based therapy, or therapy based on both an anthracycline and a taxane) can then be used to project outcomes presented in both numerical and graphical formats. Outcomes for overall survival and disease-free survival and the improvement seen in clinical trials, are reasonably modeled by Adjuvant!, although an ideal validation for all patient subsets with all treatment options is not possible. Additional speculative estimates of years of remaining life expectancy and long-term survival curves can also be produced. Help files supply general information about breast cancer. The program’s Internet links supply national treatment guidelines, cooperative group trial options, and other related information.

CONCLUSION: The computer program Adjuvant! can play practical and educational roles in clinical settings.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
M. C. U. Cheang, S. K. Chia, D. Voduc, D. Gao, S. Leung, J. Snider, M. Watson, S. Davies, P. S. Bernard, J. S. Parker, et al.
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
J Natl Cancer Inst, May 20, 2009; 101(10): 736 - 750.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M. Hickey, M. Peate, C.M. Saunders, and M. Friedlander
Breast cancer in young women and its impact on reproductive function
Hum. Reprod. Update, May 1, 2009; 15(3): 323 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. Schmidt, A. Victor, D. Bratzel, D. Boehm, C. Cotarelo, A. Lebrecht, W. Siggelkow, J. G. Hengstler, A. Elsasser, M. Gehrmann, et al.
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial
Ann. Onc., February 1, 2009; 20(2): 258 - 264.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. M. Ozanne, D. Braithwaite, K. Sepucha, D. Moore, L. Esserman, and J. Belkora
Sensitivity to Input Variability of the Adjuvant! Online Breast Cancer Prognostic Model
J. Clin. Oncol., January 10, 2009; 27(2): 214 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
P. G. Morris, H. L. McArthur, C. T. Dang, and C. A. Hudis
Selection of Appropriate Patients for Anthracycline Therapy
ASCO Educational Book, January 1, 2009; 2009(1): 11 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. V. Pandharipande, M. G. Harisinghani, E. M. Ozanne, M. C. Specht, C. Hur, J. M. Lee, and G. S. Gazelle
Staging MR Lymphangiography of the Axilla for Early Breast Cancer: Cost-Effectiveness Analysis
Am. J. Roentgenol., November 1, 2008; 191(5): 1308 - 1319.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. R. Webster, S.-F. Lee, C. Ringland, A. L. Morey, A. M. Hanby, G. Morgan, K. Byth, P. A. Mote, P. J. Provan, I. O. Ellis, et al.
Poor-Prognosis Estrogen Receptor-Positive Breast Cancer Identified by Histopathologic Subclassification
Clin. Cancer Res., October 15, 2008; 14(20): 6625 - 6633.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Paik, G. Tang, and D. Fumagalli
An Ideal Prognostic Test for Estrogen Receptor-Positive Breast Cancer?
J. Clin. Oncol., September 1, 2008; 26(25): 4058 - 4059.
[Full Text] [PDF]

Home page
 JCOHome page
S. J. Wang, C. D. Fuller, J.-S. Kim, D. F. Sittig, C. R. Thomas Jr, and P. M. Ravdin
Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy for Gallbladder Cancer
J. Clin. Oncol., May 1, 2008; 26(13): 2112 - 2117.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. S. Ross, C. Hatzis, W. F. Symmans, L. Pusztai, and G. N. Hortobagyi
Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
Oncologist, May 1, 2008; 13(5): 477 - 493.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. R. Acharya, D. S. Hsu, C. K. Anders, A. Anguiano, K. H. Salter, K. S. Walters, R. C. Redman, S. A. Tuchman, C. A. Moylan, S. Mukherjee, et al.
Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast Cancer
JAMA, April 2, 2008; 299(13): 1574 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
S. Ueda, H. Tsuda, H. Asakawa, T. Shigekawa, K. Fukatsu, N. Kondo, M. Yamamoto, Y. Hama, K. Tamura, J. Ishida, et al.
Clinicopathological and Prognostic Relevance of Uptake Level using 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) in Primary Breast Cancer
Jpn. J. Clin. Oncol., April 1, 2008; 38(4): 250 - 258.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
L. Marchionni, R. F. Wilson, A. C. Wolff, S. Marinopoulos, G. Parmigiani, E. B. Bass, and S. N. Goodman
Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer
Ann Intern Med, March 4, 2008; 148(5): 358 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. C.U. Cheang, D. Voduc, C. Bajdik, S. Leung, S. McKinney, S. K. Chia, C. M. Perou, and T. O. Nielsen
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
Clin. Cancer Res., March 1, 2008; 14(5): 1368 - 1376.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J.-A. W. Chapman, D. Meng, L. Shepherd, W. Parulekar, J. N. Ingle, H. B. Muss, M. Palmer, C. Yu, and P. E. Goss
Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer
J Natl Cancer Inst, February 20, 2008; 100(4): 252 - 260.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
F. Cardoso, L. Van't Veer, E. Rutgers, S. Loi, S. Mook, and M. J. Piccart-Gebhart
Clinical Application of the 70-Gene Profile: The MINDACT Trial
J. Clin. Oncol., February 10, 2008; 26(5): 729 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. Reimer, R. Fietkau, S. Markmann, A. Stachs, and B. Gerber
How Important is the Axillary Nodal Status for Adjuvant Treatment Decisions at a Breast Cancer Multidisciplinary Tumor Board? A Survival Analysis
Ann. Surg. Oncol., February 1, 2008; 15(2): 472 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Maraqa, M. Cummings, M. B. Peter, A. M. Shaaban, K. Horgan, A. M. Hanby, and V. Speirs
Carcinoembryonic Antigen Cell Adhesion Molecule 6 Predicts Breast Cancer Recurrence following Adjuvant Tamoxifen
Clin. Cancer Res., January 15, 2008; 14(2): 405 - 411.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. M.W. Pisters, W. K. Evans, C. G. Azzoli, M. G. Kris, C. A. Smith, C. E. Desch, M. R. Somerfield, M. C. Brouwers, G. Darling, P. M. Ellis, et al.
Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non Small-Cell Lung Cancer Guideline
J. Clin. Oncol., December 1, 2007; 25(34): 5506 - 5518.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. O. Hanrahan, A. M. Gonzalez-Angulo, S. H. Giordano, R. Rouzier, K. R. Broglio, G. N. Hortobagyi, and V. Valero
Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma
J. Clin. Oncol., November 1, 2007; 25(31): 4952 - 4960.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Desmedt, F. Piette, S. Loi, Y. Wang, F. Lallemand, B. Haibe-Kains, G. Viale, M. Delorenzi, Y. Zhang, M. S. d'Assignies, et al.
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
Clin. Cancer Res., June 1, 2007; 13(11): 3207 - 3214.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. B. Muss, L. Biganzoli, D. J. Sargent, and M. Aapro
Adjuvant Therapy in the Elderly: Making the Right Decision
J. Clin. Oncol., May 10, 2007; 25(14): 1870 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Crivellari, M. Aapro, R. Leonard, G. von Minckwitz, E. Brain, A. Goldhirsch, A. Veronesi, and H. Muss
Breast Cancer in the Elderly
J. Clin. Oncol., May 10, 2007; 25(14): 1882 - 1890.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Buyse, S. Loi, L. van't Veer, G. Viale, M. Delorenzi, A. M. Glas, M. Saghatchian d'Assignies, J. Bergh, R. Lidereau, P. Ellis, et al.
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
J Natl Cancer Inst, September 6, 2006; 98(17): 1183 - 1192.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Med. Inform. Assoc.Home page
D. R. Lairson, Y.-C. Chang, J. L. Bettencourt, S. W. Vernon, and A. Greisinger
Estimating Development Cost for a Tailored Interactive Computer Program to Enhance Colorectal Cancer Screening Compliance
J. Am. Med. Inform. Assoc., September 1, 2006; 13(5): 476 - 484.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. Thind and R. Maly
The Surgeon-Patient Interaction in Older Women With Breast Cancer: What Are the Determinants of a Helpful Discussion?
Ann. Surg. Oncol., June 1, 2006; 13(6): 788 - 793.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
B. T. Hennessy, S. Giordano, K. Broglio, Z. Duan, J. Trent, T. A. Buchholz, G. Babiera, G. N. Hortobagyi, and V. Valero
Biphasic metaplastic sarcomatoid carcinoma of the breast
Ann. Onc., April 1, 2006; 17(4): 605 - 613.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
J S Reis-Filho, C Westbury, and J-Y Pierga
The impact of expression profiling on prognostic and predictive testing in breast cancer.
J. Clin. Pathol., March 1, 2006; 59(3): 225 - 231.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. B. Chagpar
Predicting Extensive Nodal Disease in Women With Breast Cancer
Ann. Surg. Oncol., January 1, 2006; 13(1): 3 - 4.
[Full Text] [PDF]

Home page
 JCOHome page
R. Rouzier, L. Pusztai, S. Delaloge, A. M. Gonzalez-Angulo, F. Andre, K. R. Hess, A. U. Buzdar, J.-R. Garbay, M. Spielmann, M.-C. Mathieu, et al.
Nomograms to Predict Pathologic Complete Response and Metastasis-Free Survival After Preoperative Chemotherapy for Breast Cancer
J. Clin. Oncol., November 20, 2005; 23(33): 8331 - 8339.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
N. E. Davidson, M. Morrow, D. B. Kopans, and F. C. Koerner
Case 35-2005 -- A 56-Year-Old Woman with Breast Cancer and Isolated Tumor Cells in a Sentinel Lymph Node
N. Engl. J. Med., November 17, 2005; 353(20): 2177 - 2185.
[Full Text] [PDF]

Home page
 JCOHome page
B. T. Hennessy, S. Krishnamurthy, S. Giordano, T. A. Buchholz, S. W. Kau, Z. Duan, V. Valero, and G. N. Hortobagyi
Squamous Cell Carcinoma of the Breast
J. Clin. Oncol., November 1, 2005; 23(31): 7827 - 7835.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. Cianfrocca and W. J. Gradishar
Controversies in the Therapy of Early Stage Breast Cancer
Oncologist, November 1, 2005; 10(10): 766 - 779.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
L. Balducci
Squaring the Circle: Adjuvant Chemotherapy for Older Women With Breast Cancer
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2005; 60(9): 1135 - 1136.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. K. Krzyzanowska and I. F. Tannock
Should Screen-detected Breast Cancers Be Managed Differently?
J Natl Cancer Inst, August 17, 2005; 97(16): 1170 - 1171.
[Full Text] [PDF]

Home page
 Med Decis MakingHome page
P. B. Peele, L. A. Siminoff, Y. Xu, and P. M. Ravdin
Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk Information
Med Decis Making, May 1, 2005; 25(3): 301 - 307.
[Abstract] [PDF]

Home page
 JCOHome page
I. A. Olivotto, C. D. Bajdik, P. M. Ravdin, C. H. Speers, A. J. Coldman, B. D. Norris, G. J. Davis, S. K. Chia, and K. A. Gelmon
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
J. Clin. Oncol., April 20, 2005; 23(12): 2716 - 2725.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. J. Whelan and C. Loprinzi
Physician/Patient Decision Aids for Adjuvant Therapy
J. Clin. Oncol., March 10, 2005; 23(8): 1627 - 1630.
[Full Text] [PDF]

Home page
 JCOHome page
L. J. van't Veer, S. Paik, and D. F. Hayes
Gene Expression Profiling of Breast Cancer: A New Tumor Marker
J. Clin. Oncol., March 10, 2005; 23(8): 1631 - 1635.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. Cady
Simplification of Breast Cancer Surgery
Ann. Surg. Oncol., January 1, 2005; 12(1): 6 - 8.
[Full Text] [PDF]

Home page
 JCOHome page
A. Schott and D. F. Hayes
Adjuvant Chemotherapy for Elderly Women With Hormone Receptor-Positive Breast Cancer: An Old(er) Problem
J. Clin. Oncol., December 1, 2004; 22(23): 4660 - 4662.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. D. Atkins
Re: Influence of the New AJCC Breast Cancer Staging System on Sentinel Lymph Node Positivity and False-Negative Rates
J Natl Cancer Inst, November 3, 2004; 96(21): 1639 - 1639.
[Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
M. S. Donaldson
Taking Stock of Health-Related Quality-of-Life Measurement in Oncology Practice in the United States
J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 155 - 167.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. M. O'Regan
Do Tumors Detected by Mammography Screening Have a Favorable Prognosis?
JAMA, September 1, 2004; 292(9): 1062 - 1063.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
N. F. Col, G. Weber, A. Stiggelbout, J. Chuo, R. D'Agostino, and P. Corso
Short-term Menopausal Hormone Therapy for Symptom Relief: An Updated Decision Model
Arch Intern Med, August 9, 2004; 164(15): 1634 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. K. Chia, C. H. Speers, C. J. Bryce, M. M. Hayes, and I. A. Olivotto
Ten-Year Outcomes in a Population-Based Cohort of Node-Negative, Lymphatic, and Vascular Invasion-Negative Early Breast Cancers Without Adjuvant Systemic Therapies
J. Clin. Oncol., May 1, 2004; 22(9): 1630 - 1637.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Goldhirsch, W. C. Wood, R. D. Gelber, A. S. Coates, B. Thurlimann, and H.-J. Senn
Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer
J. Clin. Oncol., September 1, 2003; 21(17): 3357 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
C. E. Holmes and H. B. Muss
Diagnosis and Treatment of Breast Cancer in the Elderly
CA Cancer J Clin, July 1, 2003; 53(4): 227 - 244.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
T. Whelan, C. Sawka, M. Levine, A. Gafni, L. Reyno, A. Willan, J. Julian, S. Dent, H. Abu-Zahra, E. Chouinard, et al.
Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer
J Natl Cancer Inst, April 16, 2003; 95(8): 581 - 587.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Sonpavde
Communicating the Value of Adjuvant Chemotherapy
J. Clin. Oncol., March 1, 2003; 21(5): 948 - 949.
[Full Text] [PDF]

Home page
 JCOHome page
T. Whelan
A Trial of Two Questions
J. Clin. Oncol., October 15, 2002; 20(20): 4135 - 4138.
[Full Text] [PDF]

Home page
 JCOHome page
C. A. Bunnell and E. P. Winer
Lumping Versus Splitting: The Splitters Take This Round
J. Clin. Oncol., September 1, 2002; 20(17): 3576 - 3577.
[Full Text] [PDF]

Home page
 JCOHome page
N. L. Keating, E. Guadagnoli, M. B. Landrum, C. Borbas, and J. C. Weeks
Treatment Decision Making in Early-Stage Breast Cancer: Should Surgeons Match Patients' Desired Level of Involvement?
J. Clin. Oncol., March 15, 2002; 20(6): 1473 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
P. A. Ganz, K. A. Desmond, B. Leedham, J. H. Rowland, B. E. Meyerowitz, and T. R. Belin
Quality of Life in Long-Term, Disease-Free Survivors of Breast Cancer: a Follow-up Study
J Natl Cancer Inst, January 2, 2002; 94(1): 39 - 49.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
M. Levine and T. Whelan
Decision-Making Process--Communicating Risk/Benefits: Is There an Ideal Technique?
J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 143 - 145.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Silva, G. Dominguez, J. Silva, J. M. Garcia, A. Sanchez, O. Rodriguez, M. Provencio, P. Espana, and F. Bonilla
Detection of Epithelial Messenger RNA in the Plasma of Breast Cancer Patients Is Associated with Poor Prognosis Tumor Characteristics
Clin. Cancer Res., September 1, 2001; 7(9): 2821 - 2825.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. M. Sleeper, S. M. Sorscher, L. L. Dietrich, C. L. Loprinzi, and S. D. Thome
Assessing Adjuvant Breast Cancer Therapy Benefit
J. Clin. Oncol., June 15, 2001; 19(12): 3157 - 3159.
[Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2001 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online